NCT06088498 is a Phase 2 clinical trial of Updating Existing Smartphone App in Smoking, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Who is sponsoring NCT06088498?

NCT06088498 is sponsored by H. Lee Moffitt Cancer Center and Research Institute.

What drugs are being tested in NCT06088498?

Interventions in NCT06088498: Updating Existing Smartphone App, Quitline Services, Quitline Services and Smartphone App.

Is NCT06088498 still recruiting?

NCT06088498 is currently recruiting now. Last updated 9 February 2026.

Last reviewed 2026-02-09 · How we verify

NCT06088498

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

App for Reducing Cravings to Smoke

Recruiting now Phase 2 Last updated 9 February 2026

What this trial tests

Phase 2 trial testing Updating Existing Smartphone App in Smoking in 3,600 participants. Currently enrolling.

Timeline

11 June 2024

Primary endpoint
1 May 2027

1 May 2027

Quick facts

Lead sponsor	H. Lee Moffitt Cancer Center and Research Institute
Phase	Phase 2
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	3,600
Start date	11 June 2024
Primary completion	1 May 2027
Estimated completion	1 May 2027
Sites	1 location across United States

Drugs / interventions tested

Updating Existing Smartphone App
Quitline Services
Quitline Services and Smartphone App

Conditions studied

Smoking — all drugs for Smoking →

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Who can join

18 and older, any sex, with Smoking. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall goal of the study is to assess the efficacy of using cue exposure delivered via a smartphone application as an adjunct to Tobacco Quitline treatment to improve smoking abstinence.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Using augmented reality to deliver cue exposure treatment for smoking cessation: App usability findings and protocol for a randomized controlled trial.
Poudel R, Dougan SO, Yates H, Sawyer L, et al · · 2025 · cited 1× · PMID 39880329 · DOI 10.1016/j.cct.2025.107827
Glitches to growth: Lessons learned from developing and testing an augmented reality smartphone app for substance use treatment.
Horta M, Poudel R, Brandon KO, Dougan SO, et al · · 2025 · PMID 41411021 · DOI 10.1037/pha0000815

Verify or expand the search:

Other recruiting trials for Smoking

Currently open trials in the same condition.

NCT07488741 — Comparison of the Effects of Different Chest Techniques on University Students With Smoking Addiction · NA · recruiting
NCT07443631 — Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants · NA · recruiting
NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products · NA · recruiting
NCT06966258 — Inspire HER: Inspiring the Heart and Emotions for Radical Health · NA · recruiting
NCT06713603 — Technology Assisted Motivational Interviewing · NA · recruiting

Other H. Lee Moffitt Cancer Center and Research Institute trials

Trials by the same sponsor.

NCT05041335 — Wet Heparinized Suction for Abdominal Cancer · NA · not yet recruiting
NCT07222995 — Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs · NA · recruiting
NCT06047977 — Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors · Phase 1 · recruiting
NCT06121180 — Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma · Phase 2 · recruiting
NCT06193486 — Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06088498 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by H. Lee Moffitt Cancer Center and Research Institute
Last refreshed: 9 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06088498.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing